SBC Stock Analysis: Buy, Sell, or Hold?
SBC - SBC Medical Group Holdings Incorporated Common Stock
$3.16
0.10 (3.27%)
▲
5d:
-0.94%
30d:
-2.77%
90d:
-4.53%
BUY
HIGH Confidence
Analysis Updated: Aug 3, 2026 12:00 AM ET
Earnings: Aug 12, 2026
7d
Get Alerted When SBC Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: SBC trading at deep discount. Market pricing in -5.2% annual earnings decline, creating value opportunity for patient investors.
✅ BUY SIGNAL: SBC trading at deep discount. Market pricing in -5.2% annual earnings decline, creating value opportunity for patient investors.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$4.58
Based on 4.1% avg growth
INTRINSIC VALUE TODAY
$2.84
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 7.7x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: SBC is currently trading at $3.16, which is considered slightly high relative to its 30-day fair value range of $2.99 to $3.18. From a valuation perspective, the stock is trading at a discount (Forward PE: 6.5) compared to its historical average (7.7). Remarkably, the market is currently pricing in an annual earnings decline of 5.2% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, SBC is in a strong downtrend. The price is approaching resistance at $3.25. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 3.3% recently.
Market Sentiment: SBC has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $8.50 (+169.0%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, SBC is in a strong downtrend. The price is approaching resistance at $3.25. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 3.3% recently.
Market Sentiment: SBC has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $8.50 (+169.0%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$2.99 -
$3.18
Company Quality Score
47/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
81.0%
All Signals
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+3.3%)
- BULLISH: Trading 169.0% below Wall St target ($8.50)
Trading Range Analysis
30-Day Trading Range
$2.99 -
$3.18
Current vs Trading Range
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$2.86
Resistance Level
$3.25
Current Trend
Strong Downtrend
Technical data as of
Aug 3, 2026
Fundamental Context
Forward P/E (Next Year Est.)
6.52
Wall Street Target
$8.50
(+169.0%)
Revenue Growth (YoY)
-9.0%
Earnings Growth (YoY)
-47.1%
Profit Margin
24.1%
Valuation Discount vs History
-5.2% cheaper
PE vs Historical
6.5 vs 7.7
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-5.2%
(market-implied from PE analysis)
1-Year Target
$3.00
(-5%)
2-Year Target
$2.84
(-10%)
3-Year Target
$2.69
(-15%)
3-Yr Target (if PE normalizes)
(PE: 7→8)
$3.18
(+1%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 20.7, Growth: 4.3%)
$11.41
(+261%)
Base:
(SPY PE: 6.5, Growth: 4.3%)
$3.59
(+14%)
Bear:
(PE: 5.5, Growth: 4.3%)
$3.05
(-4%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (8x PE), but valuation improves significantly next year (7x PE) as earnings recover.
Trailing PE: 7.65 | Current EPS (TTM): $0.40
Bull Case
$4.08
(+29%)
Analyst growth 21.2%, PE expands to 8.4
Base Case
$3.71
(+17%)
Market implied 21.2%, PE stable at 7.7
Bear Case
$2.08
(-34%)
Severe decline -20.0%, PE contracts to 6.5
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 6.5 to 7.7
Stabilization Target:
$3.73
(+18.2%)
PE Expansion Potential:
+18.2%
Share & Embed Analysis
Last updated: August 04, 2026 9:10 AM ET
Data refreshes hourly during market hours. Next update: 10:10 AM
Data refreshes hourly during market hours. Next update: 10:10 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SBC showing a specific setup today?
Insider Activity (6 Months)
0
Buys
2
Sells
Net
INSIDERS SELLING
Recent Transactions
Yoshiyuki Aikawa
SELL
3100000 shares
2026-04-21
Yoshiyuki Aikawa
SELL
4422900 shares
2026-03-06
Top Rated Consulting Services Stocks
Top-rated stocks in Consulting Services by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
EFX
Equifax Inc |
BUY
23 analysts |
$211 | 50 HOLD |
|
VRSK
Verisk Analytics Inc |
HOLD
18 analysts |
$237 | 54 HOLD |
|
HURN
Huron Consulting Group I… |
STRONG BUY
5 analysts |
$189 | 51 HOLD |
|
BAH
Booz Allen Hamilton Hold… |
HOLD
14 analysts |
$86 | 46 HOLD |
|
ICFI
ICF International Inc |
BUY
5 analysts |
$105 | 53 HOLD |
